Nathalie Ivanoff
- Patient reported outcomes for the measurement of physical activity in COPD patients. The PROactive toolsBy Elena Gimeno-Santos, Yogini Raste, Zafiris Louvaris, Corina de Jong, Heleen Demeyer, Roberto Rabinovich, Nicholas Hopkinson, Iannis Vogiatzis, Karoly Kulich, Damijan Erzen, Maggie Tabberer, Milo Puhan, Nathalie Ivanoff, Xavier Basagaña, Ignasi Serra, Pim de Boer, Fabienne Dobbels, Thys van der Molen, Michael Polkey, Thierry Troosters, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainYogini Raste2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomZafiris Louvaris3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceCorina de Jong4Department of General Practice, University Medical Center Groningen, Groningen, NetherlandsHeleen Demeyer5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumRoberto Rabinovich6ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, the University of Edinburgh, Edinburgh, United KingdomNicholas Hopkinson2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomIannis Vogiatzis3Department of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, National & Kapodistrian University of Athens, M' Simou and GP Livanos Laboratories, Thorax Foundation, Athens, GreeceKaroly Kulich7Respiratory Department, Novartis, Basel, SwitzerlandDamijan Erzen8Boehringer Ingelheim Pharma GmbH & Co., KG Clinical Research - Respiratory, Ingelheim am Rhein, GermanyMaggie Tabberer9Global Health Outcomes, GlaxoSmithKline, Brentford, United KingdomMilo Puhan10Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandNathalie Ivanoff11Respiratory Department, Almirall, Sant Feliu de Llobregat, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainIgnasi Serra1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainPim de Boer12Lung, Netherlands Asthma Foundation, Amersfoort, NetherlandsFabienne Dobbels13Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Leuven, BelgiumThys van der Molen14Department of Primary Care, University of Groningen, UMCG, Groningen, NetherlandsMichael Polkey2NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield, NHS Foundation Trust and National Heart & Lung Institute, Imperial College London, London, United KingdomThierry Troosters5Department of Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumNiklas Karlsson15R&D, Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, Spain
- The PROactive innovative conceptual framework on physical activityBy Fabienne Dobbels, Corina de Jong, Ellen Drost, Janneke Elberse, Chryssoula Feridou, Laura Jacobs, Roberto Rabinovich, Anja Frei, Milo A. Puhan, Willem I. de Boer, Thys van der Molen, Kate Williams, Hillary Pinnock, Thierry Troosters, Niklas Karlsson, Karoly Kulich, Katja Rüdell and the PROactive consortiumFabienne Dobbels1Health Services and Nursing Research, University of Leuven, Leuven, BelgiumCorina de Jong2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands13These authors equally contributedEllen Drost3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UK13These authors equally contributedJanneke Elberse4Lung Foundation Netherlands, Amersfoort, The Netherlands13These authors equally contributedChryssoula Feridou5Dept of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, Greece13These authors equally contributedLaura Jacobs1Health Services and Nursing Research, University of Leuven, Leuven, Belgium13These authors equally contributedRoberto Rabinovich3ELEGI Laboratory, Center for Inflammation Research, University of Edinburgh, Edinburgh, UKAnja Frei6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandMilo A. Puhan6Horten Centre and Institute of Social and Preventive Medicine, University of Zurich, Zurich, SwitzerlandWillem I. de Boer4Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen2Dept of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKate Williams7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UKHillary Pinnock8Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UKThierry Troosters9Dept of Rehabilitation Sciences, University of Leuven, Leuven, BelgiumNiklas Karlsson10AstraZeneca, Research and Development, Health Economics and Outcomes Research, Medical Science, Mölndal, SwedenKaroly Kulich11Patient Reported Outcomes Division, Novartis, Basel, SwitzerlandKatja Rüdell7Outcomes and Evidence, Global Health and Value, Pfizer, Walton Oaks, UK12For a list of the PROactive consortium members see the Acknowledgements section
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.